Pictet Asset Management (UK)’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Pictet Asset Management (UK)’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,052,342	Closed	-$9.92K	–	1035
2018 Q4	$9.92K	Sell	1,052,342 -13,679	-1%	-$206K	0.02%	508
2018 Q3	$21.5M	Buy	1,066,021 +121,594	+13%	+$3.18M	0.05%	402
2018 Q2	$27.5M	Sell	944,427 -92,514	-9%	-$2.86M	0.07%	329
2018 Q1	$30.9M	Buy	1,036,941 +130,485	+14%	+$4.21M	0.08%	308
2017 Q4	$29.2M	Buy	906,456 +525,024	+138%	+$17.2M	0.08%	315
2017 Q3	$13.3M	Buy	+381,432	New	+$12.3M	0.04%	444

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VMI

VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pictet Asset Management (UK)'s LJPC Position: Q1 2019 in Review

Pictet Asset Management (UK) sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 1,052,342 shares — an estimated $9.92K sold.

Pictet Asset Management (UK) first reported a position in LJPC in Q3 2017 and held it in 6 quarters. The position peaked at $30.9M in Q1 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

Pictet Asset Management (UK) reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
Pictet Asset Management (UK) sold 1,052,342 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $9.92K.
Pictet Asset Management (UK) first reported a position in La Jolla Pharmaceutical Company in Q3 2017 and held it in 6 quarters.
Pictet Asset Management (UK)'s La Jolla Pharmaceutical Company position peaked at $30.9M in Q1 2018.
80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2019, filed 10 May 2019.